CTI Life Sciences Fund L.P. — Full Portfolio

Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.

BiotechDeep TechHealthtechMedical DevicesMississauga

AMArun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMBMathieu Burtnyk(Chief Operating Officer)inTTTom Tamberrino(Chief Commercial Officer)

BoardJean-Francois Pariseau(Director)DLDamian Lamb(Director)

Co-investorsFAFACIT (Fight Against Cancer Innovation Trust)GEGenesys Capital

BiotechSouth San Francisco, US

Grant E. Pickering(Chief Executive Officer)Ashish Khanna(Executive Officer)Jeff Fairman(Executive Officer)

BoardTracy Saxton(Director)William Newell(Director)KVKurt von Emster(Director)in

Co-investorsABAbingworthFOForesite CapitalFRFrazier Life SciencesJAJanus Henderson InvestorsLOLongitude CapitalMEMedicxi+4 more

Vaxcyte develops broad-spectrum vaccines to prevent bacterial infections, using a cell-free protein synthesis platform and synthetic chemistry techniques.

BiotechHealthtech

GPGrant Pickering(Founder)inGEGrant E. Pickering(Chief Executive Officer and Director)in

Co-investorsBIBioRock VenturesFOForesite CapitalFRFrazier Life SciencesLOLongitude CapitalRARA CapitalJAJanus Henderson Investors+2 more

Thryv Therapeutics is a clinical-stage biotechnology company developing selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) for inherited cardiac arrhythmias such as Long QT Syndrome and acquired cardiometabolic diseases.

BiotechHealthtechMedical Devices

PFPaul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra OdinkinASAmy Sehnertin

Co-investorsAMAmzak HealthADadMare BioInnovationsALAlexandriaLULumira Ventures

Oligon Therapeutics develops RNA-based multi-targeting drugs using its SeekR platform, which combines RNA aptamer oligo-binders with siRNA silencers into a single self-delivering molecule for precise targeting of specific cell types, including T-cells and cancer cells.

AI & Machine LearningBiotech

SMSpyro Mousses(Founder)in

Co-investorsFOFonds de solidarité FTQ

Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).

BiotechDigital HealthMedical Devices

PFPaul F. Truex(Chairman of the Board & Chief Executive Officer)inDODebra Odink(President & Chief Development Officer)inASAmy Sehnert(Chief Medical Officer)inMKMatt Killeen(Chief Business Officer)in

BoardSDSaumya Das(Chief Scientific Advisor)

Co-investorsLULumira VenturesADadMare BioInnovationsAMAmzak HealthFOFonds de solidarité FTQ

AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs.

BiotechDigital HealthHealthtechMedical DevicesGirona, ES

CDCarles Domenech(Founder)in

Co-investorsCACapital CellINInveready Technology Investment Group

Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing selective small molecule inhibitors to treat rare genetic and age-related diseases caused by dysregulated cellular metabolism.

BiotechBerkeley, US

Allison J. Hulme(CEO & President)inJKJohn Kincaid(Chief Scientific Officer)inDRDavis Ryman(Executive Officer)inMZMicah Zajic(Executive Officer)inIan Massey(Executive Officer)Stelios Tzannis(Executive Officer, Director)

Co-investorsCOCoastCapFJFJ LabsSOSofinnova VenturesVEvenBio PartnersAPApollo Health VenturesVEvenBio Global Strategic

Apollo is a venture capital firm that invests in life-science and biotechnology startups, combining entrepreneurial expertise with deep scientific knowledge to support early-stage companies in drug development and personalized medicine.

BiotechDeep TechHealthtechLongevity

NRNils Regge(Co-Founder & General Partner)in

Co-investorsBLBLN CapitalCOCoastCapFJFJ LabsKFKfW CapitalTRTruVenturo GmbHFOForesite Capital+3 more

Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation.

BiotechDigital Health

Co-investors3B3B Future Health FundADadMare BioInnovationsPAPanacea VentureSESeventure Partners

enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.

BiotechMedical Devices

Co-investorsLULumira Ventures

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.

AI & Machine LearningBiotechHealthtechMontreal, CA

CPClaude PerreaultPTPierre Thibault

Co-investorsADAdvent Life SciencesCACambridge Innovation CapitalADadMare BioInnovationsFOFonds de solidarité FTQ

Find Therapeutics is a clinical-stage biopharmaceutical company developing therapies to treat demyelinating diseases, particularly multiple sclerosis and related conditions affecting myelin repair.

BiotechLongevityMedical DevicesMontreal, CA

Co-investorsADadMare BioInnovations

Phenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology.

AI & Machine LearningBiotechDeep TechToronto, CA

SCSam Cooper(Co-founder & CTO)inOKOren Kraus(Co-founder)in

Co-investorsCACantos VenturesAVAV8 VenturesGAGarage CapitalHEHemi Ventures, LlcTOToronto Innovation Acceleration PartnersHIHike Ventures+1 more

A URL shortcut operated by Google that directs users to official Google products and services.

Co-investorsFIFirst Bight VenturesSWSwanlaab Venture FactoryABAbstract VenturesGEGeneral CatalystUNUnion Square Ventures (USV)Y Y Combinator

A biologics center of excellence focused on developing and delivering medicines to patients, operating as a subsidiary within the Otsuka pharmaceutical group.

AI & Machine LearningBiotechHealthtechMedical Devices

Zachary Shriver(President and Chief Executive Officer)KVKarthik Viswanathan(Vice President, Research)in

Co-investorsCYCycad Group LLCLULux CapitalMRMRL Ventures Fund